Editorial: Steroids and the brain, volume II
Takayoshi Ubuka, Vance L. Trudeau

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmacological Effects and Toxicity Studies · Stress Responses and Cortisol · Neuroscience and Neuropharmacology Research
Steroids are lipophilic chemicals that are composed of the perhydrocyclopentanophenanthrene four ring stricture. Steroid hormones are synthesized in the gonads, adrenals, other endocrine glands and nervous tissues, and exert various effects. Steroids and their nuclear and membrane receptors play significant roles in broad functions of the brain, such as regulation of reproduction, stress, socio-sexual behavior, aggression, cognition, mood, emotion, learning and memory.
The brain is not only the target of steroid hormones produced in the periphery but is a major site of de novo synthesis and catalysis (1–3). Malfunction or chemical disruption of steroid signaling is related to a variety of mental disorders such as gender dysphoria, anxiety, depression, autism spectrum disorder, cancer, and aging-related disorders such as Alzheimer’s disease (4, 5).
Following the first volume of Steroids and the Brain (6), this Research Topic has assembled basic and advanced knowledge in various aspects of steroid functions in the brain, ranging from evolutionary and physiological viewpoints to their involvement in neuropathological conditions. The articles include the role of steroids in autism, depression, stress, inflammation, and reproduction.
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that is characterized by impaired communication, low interest, and repetitive behaviors. Both genetic and environmental factors are reported to play important roles in the etiology of ASD. In the USA, for example, the incidence of ASD is 1/36 among 8-year-old children (7). The 4-6:1 male to female ratio in the incidence of ASD (8), implicates sex steroids in such sex differences. Wang et al. conducted a systematic review with meta-analysis to summarize blood, urine, or saliva androgen levels in ASD individuals. It was found that androgen levels were significantly higher in ASD individuals compared to control. Subgroup analyses performed by age, sex, sample source, and measurement method showed significantly elevated levels of urinary total testosterone, urinary dehydroepiandrosterone, and free testosterone in ASD individuals. In particular, dehydroepiandrosterone levels were significantly elevated in ASD males.
Depression is more common in people with epilepsy. In a study that used the Zung Self-Reported Depression Scale, depression occurred in 26.9% of patients with epilepsy compared with 9.7% in the control cohort (9). Women with epilepsy face particular challenges with seizures and anti-seizure medications (ASMs) (10). Ogunjimi et al. investigated the association of hormones related to reproduction, including sex steroids, ASM, and depression among epileptic women. Blood samples were collected during the luteal phase (LP) and follicular phase (FP). There were statistical differences between cases and controls in testosterone and prolactin. Testosterone, FP follicle-stimulating hormone (FSH), FP estradiol, LP FSH, LP progesterone, and LP prolactin were associated with depression. Differences in various hormonal levels in epileptic women were also found by using different ASMs, such as carbamazepine and levetiracetam.
Why are there sex differences in the responses to stressors? Previous studies characterized the roles of androgens in mediating the sex differences in neuroendocrine and behavioral stress responses (11). Amaya et al. investigated whether glucocorticoid signaling in the brain may be modulated by androgens. They compared the expression of glucocorticoid receptor (GR) target genes in the brain regions where GR and androgen receptor (AR) are co-expressed after chronic treatment with corticosterone, dihydrotestosterone, combination of both, or corticosterone in combination with the AR antagonist enzalutamide. Their results showed that androgens affected glucocorticoid signaling only in the prefrontal cortex and the substantia nigra, and not in the hypothalamus, hippocampus, and ventral tegmental area. This study highlights the role of the prefrontal cortex and the substantia nigra in mediating the sex differences in the responses to stressors.
Inflammation in the brain and periphery have recently been recognized as playing critical roles in the development and progression of neurological and psychiatric disorders (12). Neurosteroids such as pregnenolone and allopregnanolone emerged as regulators of inflammatory and neuroinflammatory responses (13). Previous studies demonstrated the inhibitory effect of allopregnanolone on the activation of inflammatory toll-like receptor 4 (TLR4) signaling in RAW264.7 macrophages and the brain of alcohol-preferring rats. Balan et al. investigated the impact of allopregnanolone on the levels of interleukin-10, an anti-inflammatory mediator cytokine, and activation of the TRIF-dependent endosomal TLR4 pathway. Their results demonstrate allopregnanolone enhancement of the endosomal TRL4-TRIF anti-inflammatory signals and elevations of interleukin-10 in the male alcohol-preferring rat brain but not in females.
The rate limiting step for the synthesis of the estrogens involves aromatase (Cyp19a1) that respectively converts the androgens androstenedione and testosterone into the bioactive estrogens, estrone and estradiol. Teleosts, the bony fishes, have two paralogous aromatase genes, cyp19a1a and cyp19a1b, that are highly expressed in the ovary and the brain, respectively. It was recently shown that cyp19a1b mutant female zebrafish that have significantly lower estradiol levels in the brain also have altered female sexual behavior (14). Although brain aromatase is constitutively expressed in neurons in mice, cyp19a1b is exclusively expressed in radial glial cells in teleosts. Shaw et al. investigated the mechanistic pathways of cyp19a1b mutant female zebrafish in the disruption of female reproductive behavior. They found that delayed oviposition in female mutant *cyp19a1b^-/-^
- zebrafish is linked to impaired arginine vasopressin (also known and vasotocin in teleosts) signaling in the brain. This study also suggests that female behavioral phenotype of *cyp19a1b^-/-^
- zebrafish is a consequence of impaired processing of arginine vasopressin-dependent social cues important for mate identification and assessment.
Together, Volume I and Volume II “Steroids and the Brain” offer a broad perspective on the diverse roles of steroids in the normal vertebrate brain, under stressful conditions, or their associations with numerous neurological disorders. The emergence of methods designed for neuron-specific genetic modifications of steroidogenic enzymes and steroid receptors, coupled with single-cell transcriptomics and proteomics lays the foundation for future studies that will expand the role of steroids, and may provide novel routes for therapy.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Baulieu EE. Neurosteroids: a new function in the brain. Biol Cell. (1991) 71:3–10. doi: 10.1016/0248-4900(91)90045-O 1912947 · doi ↗ · pubmed ↗
- 2Baulieu EE Robel P Schumacher M. Neurosteroids: beginning of the story. Int Rev Neurobiol. (2001) 46:1–32. doi: 10.1016/S 0074-7742(01)46057-0 11599297 · doi ↗ · pubmed ↗
- 3Le Goascogne C Robel P Gouézou M Sananès N Baulieu EE Waterman M. Neurosteroids: cytochrome P-450scc in rat brain. Science. (1987) 237:1212–5. doi: 10.1126/science.3306919 3306919 · doi ↗ · pubmed ↗
- 4Vaudry H Ubuka T Soma KK Tsutsui K. Editorial: recent progress and perspectives in neurosteroid research. Front Endocrinol (Lausanne). (2022) 13:951990. doi: 10.3389/fendo.2022.951990 35966056 PMC 9365233 · doi ↗ · pubmed ↗
- 5Ubuka T Tsutsui K. Neuropeptidergic control of neurosteroids biosynthesis. Front Neuroendocrinol. (2022) 65:100976. doi: 10.1016/j.yfrne.2021.100976 34999057 · doi ↗ · pubmed ↗
- 6Ubuka T Trudeau VL Parhar I. Editorial: steroids and the brain. Front Endocrinol (Lausanne). (2020) 11:366. doi: 10.3389/fendo.2020.00366 32582033 PMC 7283457 · doi ↗ · pubmed ↗
- 7Maenner MJ Warren Z Williams AR Amoakohene E Bakian AV Bilder DA. Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2020. MMWR Surveill Summ. (2023) 72:1–14. doi: 10.15585/mmwr.ss 7202 a 1 PMC 1004261436952288 · doi ↗ · pubmed ↗
- 8Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry. (2005) 66(Suppl 10):3–8.16401144 · pubmed ↗
